Suicide among Danes with multiple sclerosis

Brønnum-Hansen, H.; Stenager, E.; Stenager, E. Nylev; Koch-Henriksen, N.; Brønnum-Hansen, H; Nylev Stenager, E
October 2005
Journal of Neurology, Neurosurgery & Psychiatry;Oct2005, Vol. 76 Issue 10, p1457
Academic Journal
journal article
Objective: To compare the suicide risk among Danish citizens with multiple sclerosis with that of the general population, and to evaluate changes over 45 years.Methods: The study was based on linkage of the Danish Multiple Sclerosis Registry to the Cause of Death Registry. It comprised all 10,174 persons in whom multiple sclerosis was diagnosed in the period 1953 to 1996. The end of follow up was 1 January 1999. Standardised mortality ratios (SMRs) were calculated for various times after diagnosis and for age and calendar period of diagnosis.Results: In all, 115 persons (63 men, 52 women) had taken their own lives, whereas the expected number of suicides was 54.2 (29.1 men, 25.1 women). Thus the suicide risk among persons with multiple sclerosis was more than twice that of the general population (SMR = 2.12). The increased risk was particularly high during the first year after diagnosis (SMR = 3.15).Conclusions: The risk of suicide in multiple sclerosis was almost twice as high as expected more than 20 years after diagnosis. The excess suicide risk has not declined since 1953.


Related Articles

  • Italian studies on early-onset multiple sclerosis: the present and the future. Ghezzi, A.; Ruggieri, M.; Trojano, M.; Filippi, M. // Neurological Sciences;Nov2004 Supplement 4, Vol. 25, pS346 

    This article focuses on various Italian studies on multiple sclerosis. Over the last few years some studies have been published in Italy evaluating the features at presentation, the natural history and outcome of multiple sclerosis (MS) with onset during childhood or adolescence, and the...

  • miRNA in multiple sclerosis: search for novel biomarkers. Gandhi, Roopali // Multiple Sclerosis Journal;Aug2015, Vol. 21 Issue 9, p1095 

    A major challenge in multiple sclerosis (MS) is to develop biomarkers that could help in understanding individual MS patients, i.e. whether they are a responder or non-responder to therapy, which medicine is more effective, and the degree to which they may be entering the progressive phase of...

  • Depression in multiple sclerosis: A long-term longitudinal study. Koch, Marcus W; Patten, Scott; Berzins, Sandy; Zhornitsky, Simon; Greenfield, Jamie; Wall, Winona; Metz, Luanne M // Multiple Sclerosis Journal;Jan2015, Vol. 21 Issue 1, p76 

    The article presents a study that examines the long-term prognosis of multiple sclerosis (MS). The study investigates the changes in Center for Epidemiological Studies Depression Scale (CESD) scores in MS patients over four years of follow-up. It reveals that depression in MS is largely chronic,...

  • Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome. Paulseth, J. E. Rick // ACP Journal Club;1/19/2010, Vol. 152 Issue 1, p9 

    The article discusses a study conducted by professor G. Comi and colleagues to know whether glatiramer acetate delays conversion to clinically definite multiple sclerosis (MS) in patients with clinically isolated syndrome (CIS). A randomized placebo-controlled trial was conducted in 481 patients...

  • Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring. Alcalde-Cabero, Enrique; Almazán-Isla, Javier; García-Merino, Antonio; de Sá, Joao; de Pedro-Cuesta1, Jesús // BMC Neurology;2013, Vol. 13 Issue 1, p1 

    Background: A debate surrounding multiple sclerosis epidemiology has centred on time-related incidence increases and the need of monitoring. The purpose of this study is to reassess multiple sclerosis incidence in the European Economic Area. Methods: We conducted a systematic review of...

  • THE PREVALENCE AND CLINICAL PROFILE OF MULTIPLE SCLEROSIS IN TIMIS COUNTY, ROMANIA. Cornea, A.; Dijmarescu, C.; Tudor, R.; Petre, A.; Simu, M. // Romanian Journal of Neurology;2016, Vol. 15 Issue 3, p113 

    Introduction. Multiple sclerosis is a neurodegenerative disease for which correct prevalence and incidence data are mandatory to assess the long term health policy in terms of social and economic burden. The present study aims to evaluate the prevalence of MS and the distribution of clinical MS...

  • Causes of death among patients with multiple sclerosis. Sumelahti, Marja-Liisa; Hakama, Matti; Elovaara, Irina; Pukkala, Eero // Multiple Sclerosis (13524585);12/01/2010, Vol. 16 Issue 12, p1437 

    Background: Several studies show a high mortality risk among patients with multiple sclerosis (MS).Objectives: In this study, mortality and underlying causes of death were analysed among patients with MS diagnosed between 1964�1993 in Finland (n = 1595).Methods: Standardized mortality...

  • Clinical characteristics of multiple sclerosis with early onset. Ghezzi, A. // Neurological Sciences;Nov2004 Supplement 4, Vol. 25, pS336 

    Clinical characteristics of multiple sclerosis with early onset are described. The evolution is frequently relapsing-remitting; compared to the adult form, the EI)SS levels of 3, 4 and 6 are reached after a longer interval hut at a lower age Negative prognostic factors are a short inter-attack...

  • Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis. Martinelli, V.; Rodegher, M.; Moiola, L.; Comi, G. // Neurological Sciences;Nov2004 Supplement 4, Vol. 25, pS350 

    Late onset multiple sclerosis (LOMS), defined as the first presentation of clinical symptoms in patients over 50, is not a rare phenomenon as previously thought, since the prevalence ranges between 4% and 9.6% in different studies. The course of the disease is often primary progressive and...


Read the Article


Sign out of this library

Other Topics